FLAURA2
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FLAURA2
Oct 6, 2024, 13:47 |
Blog
Ana I. Velázquez Mañana: Lung Cancer management updates from 2024 by Weill Cornell Medicine Meyer Cancer Center
Ana I. Velázquez Mañana shared a post on X: ''Christine Garcia from Weill Cornell Medicine…
Sep 29, 2024, 06:34 |
Insight
Picks from Lung Cancer Cocktail With Science by Stephen V Liu
The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…
Aug 28, 2024, 19:52 |
Blog
Impact of baseline positive vs negative plasma Circulating tumor DNA for Estimated glomerular filtration rate in the FLAURA2 trial by Jonathan Riess
David Gandara, Co-Director-Center for Experimental Therapeutics, shared a post on X: "At Cal Cancer Consortium…
Aug 24, 2024, 11:15 |
Insight
Jill Feldman: Exciting news for the EGFR lung cancer community
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Jill Feldman on…
Aug 23, 2024, 14:21 |
Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Jul 18, 2024, 10:05 |
Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
May 3, 2024, 04:28 |
Blog
Erman Akkus: Roundup of the last year-Practice changing trials in NSCLC
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X/Twitter: "Roundup…
Apr 26, 2024, 09:26 |
Insight
Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter: ''First-line treatment…
Apr 21, 2024, 18:13 |
Blog
Antonio Passaro: An intense yet incredibly rewarding day in Oporto
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared a…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Feb 17, 2024, 15:57 |
Insight
Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…
All:
11
Posts:
1 - 100
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube